Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy
- PMID: 7521284
- DOI: 10.1016/0168-5597(94)90026-4
Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy
Abstract
We quantitated the size and configuration of compound muscle action potentials (CMAPs) in 266 nerves (66 median, 67 ulnar, 71 tibial and 62 peroneal) of 72 patients with acute inflammatory demyelinating polyneuropathy (AIDP) initially studied within 19 days of symptom onset. Results were compared with criteria for CMAP abnormalities, including criteria for abnormal negative peak duration and desynchronisation, derived from a control population of 50 median, ulnar, tibial and peroneal nerves. Other motor conduction abnormalities including minimal F response latency were also examined. We also analysed patterns of CMAP abnormality, peak disability and outcome for AIDP patients who had at least 3 motor nerves evaluated at first electrophysiologic study. Amongst AIDP nerves, low amplitude of the distal CMAP, usually with prolonged distal latency, was much more common than an abnormal fall in CMAP amplitude between stimulus sites. Using our CMAP criteria more than half of these low amplitude distal responses showed prolonged negative peak duration of desynchronisation or both, consistent with demyelination. Of the 47 AIDP patients who had 3 or more nerves initially studied, 37 (78.7%) had at least 1 motor nerve with a distal CMAP showing evidence of temporal dispersion. In addition, those with at least 75% of motor nerves showing a pattern of low amplitude of the distal CMAP without a further significant fall in amplitude between stimulus sites had greater peak disability and a poorer outcome. Assessment of temporal dispersion of the distal CMAP should be included in electrophysiologic criteria for acute demyelination. In addition, for some patients with AIDP patterns of CMAP amplitude abnormality amongst motor nerves are present early in the illness and may provide prognostic information.
Similar articles
-
Quantitative studies of F responses in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.Electroencephalogr Clin Neurophysiol. 1994 Aug;93(4):255-64. doi: 10.1016/0168-5597(94)90027-2. Electroencephalogr Clin Neurophysiol. 1994. PMID: 7521285
-
Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.Clin Neurophysiol. 2012 Oct;123(10):2099-105. doi: 10.1016/j.clinph.2012.04.002. Epub 2012 May 3. Clin Neurophysiol. 2012. PMID: 22560637
-
Acute inflammatory demyelinating neuropathy: a critical evaluation of diagnostic criteria for demyelination.Electromyogr Clin Neurophysiol. 1995 Dec;35(8):451-5. Electromyogr Clin Neurophysiol. 1995. PMID: 8773204
-
[Electrodiagnostic features in inflammatory demyelinating polyneuropathy].Rinsho Shinkeigaku. 1995 Dec;35(12):1365-7. Rinsho Shinkeigaku. 1995. PMID: 8752397 Review. Japanese.
-
[Nerve conduction abnormalities in chronic inflammatory demyelinating polyneuropathy (CIDP)].Rinsho Shinkeigaku. 1991 Dec;31(12):1333-6. Rinsho Shinkeigaku. 1991. PMID: 1817802 Review. Japanese.
Cited by
-
Electrodiagnostic subtyping in Guillain-Barré syndrome: Use of criteria in practice based on a survey study in IGOS.J Peripher Nerv Syst. 2022 Sep;27(3):197-205. doi: 10.1111/jns.12504. Epub 2022 Jun 24. J Peripher Nerv Syst. 2022. PMID: 35700346 Free PMC article.
-
Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):191-5. doi: 10.1136/jnnp.68.2.191. J Neurol Neurosurg Psychiatry. 2000. PMID: 10644786 Free PMC article.
-
Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.J Neurol. 2016 Sep;263(9):1709-18. doi: 10.1007/s00415-016-8192-2. Epub 2016 Jun 8. J Neurol. 2016. PMID: 27278064
-
Clinical features of Guillain-Barré syndrome patients with elevated serum creatine kinase levels.BMC Neurol. 2020 May 27;20(1):214. doi: 10.1186/s12883-020-01796-z. BMC Neurol. 2020. PMID: 32460711 Free PMC article.
-
Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.Acta Neurol Belg. 2021 Oct;121(5):1141-1150. doi: 10.1007/s13760-021-01603-7. Epub 2021 Feb 18. Acta Neurol Belg. 2021. PMID: 33599939
MeSH terms
LinkOut - more resources
Full Text Sources